• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 8, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Children’s Hospital of Philadelphia’s Dr. Paul Offit receives the 2018 Albert B. Sabin Gold Medal

Bioengineer by Bioengineer
April 26, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Sabin Vaccine Institute

The Sabin Vaccine Institute has awarded Paul Offit, MD, of Children's Hospital of Philadelphia (CHOP), the 2018 Albert B. Sabin Gold Medal. Sabin recognized Dr. Offit as co-inventor of an oral rotavirus vaccine and for his leadership as one of the United States' most vocal and dedicated advocates for immunization.

"Paul's contributions as a vaccinologist and advocate have improved the health of children in every corner of the world," said Amy Finan, CEO of the Sabin Vaccine Institute. "His scientific accomplishments are rivaled only by his impact as a dedicated advocate for immunization. Paul truly exemplifies Albert Sabin's commitment to ensuring every child is protected from preventable disease."

Starting in the 1980s, Dr. Offit performed early research on rotavirus alongside Dr. H Fred Clark and Dr. Stanley Plotkin. This work led to the invention of RotaTeq®, an oral vaccine that prevents rotavirus diarrhea, the most common cause of diarrheal hospitalizations and deaths among children worldwide. Since then, RotaTeq® has saved thousands of children's lives. In 2008, the vaccine became the first oral rotavirus vaccine to be prequalified by the World Health Organization. Within a decade of the vaccine's introduction in the United States, child hospitalizations from rotavirus dropped by 85 percent.

"The Albert B. Sabin Gold Medal is not an award only to me, but to Children's Hospital of Philadelphia, specifically to Drs. Stan Plotkin and Fred Clark, mentors and friends who taught me how to make a vaccine and how to use my expertise to advocate for children," said Dr. Offit. He added, "Advocacy becomes all the more important as we live in a world where scientific illiteracy is being replaced by scientific denialism. Now, more than ever before, it's time for scientists to stand up and explain what they do and why they do it to the public and the media. Science is a privilege, not a right. And it's the taxpayer, the voter, who grants us that privilege."

Dr. Offit is Director of the Vaccine Education Center, an attending physician and professor of pediatrics in the Division of Infectious Diseases at CHOP, and the Maurice R. Hilleman professor of vaccinology and a professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He has received numerous international and national awards for his work, including the Maxwell Finland Award for Outstanding Scientific Achievement from the National Foundation for Infectious Diseases, as well as Election to the National Academy of Medicine and the American Academy of Arts and Sciences. He has published more than 160 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety.

Awarded annually since 1994, the Albert B. Sabin Gold Medal recognizes a researcher who has made extraordinary contributions in the field of vaccinology or a complementary field. The award commemorates the legacy of Dr. Albert B. Sabin, who developed the oral live virus polio vaccine that is widely heralded with making a huge contribution to the near eradication of polio worldwide.

The 2018 Albert B. Sabin Gold Medal ceremony was made possible in part by the Bill & Melinda Gates Foundation.

###

About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 546-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu

Media Contact

Amy Burkholder
[email protected]
267-426-6083
@chop_research

http://www.chop.edu

Share13Tweet7Share2ShareShareShare1

Related Posts

Rainfall Patterns Linked to Mortality in Brazil

April 8, 2026

Maternal Anxiety May Negatively Impact Fetal Development, New Study Reveals

April 8, 2026

Finger-Tapping in Supranuclear Palsy Links to Brain Atrophy

April 8, 2026

Common IBS Treatments Associated with Increased Mortality Risk, Study Finds

April 8, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    98 shares
    Share 39 Tweet 25
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1010 shares
    Share 399 Tweet 250
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tackling Carbon Dioxide in Anion-Exchange Fuel Cells

Rainfall Patterns Linked to Mortality in Brazil

Antibody Drugs with Enhanced Immune Cell Binding Associated with Increased Allergic Reactions

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.